Despite scientific progress over the past 25 years, dementia remains one of the toughest health-care challenges. Alzheimer’s disease is the sixth-leading cause of death in the United States, and the number of deaths from all related dementias may be twice as high. Years of investment and research in Alzheimer’s disease and related dementias (ADRD) are sowing seeds of hope. New treatments aim to slow cognitive decline and manage symptoms. However, because of the complexity of dementia, people living with dementia will likely need a combination of drug treatments, comprehensive care, and supportive services to help them live their lives to the fullest after diagnosis.
Advocacy organizations, policymakers, researchers, and health-care professionals are developing ways to meet the complex medical and social needs of the estimated 7.2 million Americans living with ADRD and their families. To advance the adoption of comprehensive dementia-care models, the Milken Institute Alliance to Improve Dementia Care convened a roundtable in June 2021. Leaders across industry, government, research, advocacy, philanthropy, health systems, and community-based organizations explored ways to improve and pay for comprehensive dementia care.
This report presents actionable recommendations to advance comprehensive dementia care and implement effective payment policies. These recommendations center around two overarching themes:
1. Developing a structured framework to test, implement, and scale comprehensive dementia-care models; and
2. Implementing effective payment policies to incentivize adoption and participation in comprehensive dementia-care models.
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Even before the onset of the COVID-19 pandemic, the United States was confronted with a number of significant policy concerns. Today, working together to solve those challenges is more imperative than ever. The Milken Institute is committed...
Frontotemporal dementia (FTD) refers to a family of neurodegenerative conditions that cause changes in behavior, mood, executive function, language, memory, and motor function. As many as 30,000 people are living with FTD in the United...
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...
This year’s report, Building a Resilient America: The New Consensus for Action, is part of The Milken Institute-Harris Poll Listening Project, now in its fifth year, which surveys socioeconomic, institutional, and political barriers to...
In this collection of essays from the Center for the Future of Aging, experts identify challenges and opportunities in realizing the potential of healthy, productive and purposeful aging.